158.85USD+2.89%Mkt Cap: —P/E: 38.341d ago
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Mark…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value43.68B $
Revenue (TTM)7.23B $
Gross Profit3.81B $
Net Income (TTM)1.41B $
Revenue/Share25.55 USD
Last Price158.85 USD
Fiscal Year EndOct 2025
MR QuarterApr 2026
Employees18.0K
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINUS00846U1016
Valuation
P/E (Trailing)38.34
P/E (Forward)—
PEG—
EV/EBITDA21.68
EV/Revenue6.04
P/S—
P/B5.89
EPS (TTM)4.14
EPS (Forward)—
52W Range
146.7592% of range159.88
52W High159.88 USD
52W Low146.75 USD
Profitability
Gross Margin52.64%
Oper. Margin23.71%
EBITDA Margin27.86%
Profit Margin19.55%
ROE21.33%
ROA8.61%
Growth
Revenue Growth10.00%
Earnings Growth60.00%
Cash Flow & Leverage
Operating CF1.45B $
CapEx (TTM)—
FCF Margin12.87%
FCF Yield—
Net Debt1.74B $
Net Debt/EBITDA0.86
Balance Sheet
Debt/Equity49.73
Current Ratio2.10
Quick Ratio1.46
Book Value/Sh25.24 USD
Cash/Share6.398 USD
Dividends
Fwd Div Rate—
Trail. Div Rate1.006 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.318.53M
Float281.46M
Insiders0.19%
Institutions95.53%
Technical
SMA 50134.82 (+17.8%)
SMA 200123.10 (+29.0%)
Beta1.23
S&P 52W Chg20.80%
Avg Vol (30d)893
Avg Vol (10d)1.58K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—